跳至主要内容
临床试验/NCT04555421
NCT04555421Unknown不适用

Using the Lumen Device for Prediabetes Prevention

Tel-Aviv Sourasky Medical Center2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2020年10月最近更新:
适应症

试验速览

阶段
不适用
入组人数
40
试验地点
2
主要终点
Weight change

研究概览

简要总结

To examine the effect of using Lumen on metabolic parameters and anthropometric variables. This will be done from baseline to the end of a 12 weeks intervention in adults with prediabetes..

详细描述

A single arm intervention evaluation for 12 weeks (pre-post analysis) was designed for the study. After initial screening of the subjects, they will be familiarized with Lumen and will learn on how to take a measure. After 2 days of using Lumen device at home for acquaintance and calibration, subjects will arrive to the clinic and several baseline measurements will be taken, including blood samples and anthropometric variables. Then, subjects will use Lumen at home and will take a Lumen measurement each day for a period of 12 weeks. Subjects will take a Lumen measurement each morning at fasted state and will get a nutritional plan according to their result. In addition, subjects will be guided to log in the last time they consumed a meal (how long they fasted for), the duration of their sleep, and if they managed to follow the previous day recommendations. Moreover, the Lumen application will encourage the subjects to take more measurement throughout the day, in particular in response to food intake as well as before and after workouts. Lumen coach will remotely support the subjects via Lumen's mobile phone application and will provide clarifications and guidelines if needed based on the Lumen metric. Finally, subjects will return to the clinic for their final assessment which would include taking blood samples and anthropometric variables again.

The study will include 40 subjects the most with a minimal target of 30 subjects. The number of subjects was determined based on power analysis made according to a study evaluating HbA1c levels in prediabetic subjects who received low-carb diet for 12 weeks.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
25 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • BMI ≥ 27 to ≤ 40 HbA1c ≥ 5.7% to ≤6.4% Fasting glucose ≥ 100 mg/dl to ≤ 125 mg/dl Not treated with diabetes-related medications

排除标准

  • Medications:
  • Insulin and medications for glycemic control
  • Antipsychotics
  • Anti-retrovirals
  • Corticosteroids
  • Oncologic treatment
  • Thyroid hormones (if endocrinological control is good, can be included).
  • Conditions:
  • Previous diagnosis of diabetes
  • G6PD deficiency
  • Renal disease
  • Hepatic disease
  • Hematological (anemia)
  • Suffered heart attack, stroke, or transient ischemic attack in the past 6 months
  • Uncontrolled hypertension (systolic blood pressure > 180 mm Hg or diastolic blood pressure > 105 mm Hg)
  • Treatment of cancer (excluding surgery alone) within the past 2 years (excluding skin cancer)
  • Reported chest pain, shortness of breath with minimal activity or at rest, or unexplained dizziness or fainting with physical activity
  • Chronic lung disease (chronic obstructive pulmonary disease or asthma requiring oxygen therapy)
  • Personal requirements:
  • Inability to read and understand English
  • Inability to use a smartphone
  • Any issues arise with using the Lumen device and application
  • Aerobic exercise > 3 times per week
  • Active participation in diet counseling or active weight loss (> 3 kg in the past one month)
  • Change of diet or physical activity in the last 3 months

结局指标

主要结局

Weight change

时间窗: from baseline to 12 weeks

% weight change

Fat percentage

时间窗: from baseline to 12 weeks

% change in fat percentage

次要结局

  • Blood tests changes- lipid panel change(from baseline to 12 weeks)
  • Blood tests changes - glycemic control(from baseline to 12 weeks)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Using the Lumen Device for Prediabetes Prevention | 临床试验